Abstract:Background A few studies have reported that administration of lidocaine and dexmedetomidine relieves the incidence of postoperative nausea and vomiting (PONV). We explored whether combined infusion of lidocaine plus dexmedetomidine had lower occurrence of PONV undergoing laparoscopic hysterectomy with general anesthesia. Methods A total of 248 women undergoing elective laparoscopic hysterectomy were allocated into the following four groups: the control group (group C, n = 62) received an equal volume of saline, the lidocaine group (group L, n = 62) received intravenous lidocaine (bolus infusion of 1.5 mg/kg over 10 min, 1.5 mg/kg/h continuous infusion), the dexmedetomidine group (group D, n = 62) received dexmedetomidine administration (bolus infusion of 0.5 µg/kg over 10 min, 0.4 µg/kg/h continuous infusion), and the lidocaine plus dexmedetomidine group (group LD, n = 62) received combination of lidocaine (bolus infusion of 1.5 mg/kg over 10 min, 1.5 mg/kg/h continuous infusion) and dexmedetomidine administration (bolus infusion of 0.5 µg/kg over 10 min, 0.4 µg/kg/h continuous infusion). The primary outcome was the incidence of nausea, vomiting, and PONV during the first 48 h after surgery. The secondary outcomes included the incidence of total 24 h PONV after surgery, intraoperative remifentanil requirement, postoperative pain visual analogue scale (VAS) scores and fentanyl consumption, the incidence of bradycardia, agitation, shivering, and mouth dry during post-anesthesia care unit (PACU) stay period. Results The occurrence of nausea and PONV in group LD (5.0 and 8.3%) at 0–2 h after operation was lower than group C (21.7 and 28.3%) ( P < 0.05). There was no statistically significant difference with respect to occurrence of nausea and PONV in groups L (13.3 and 20.0%) and D (8.3 and 13.3%) at 0–2 h after operation compared to group C (21.7 and 28.3%). The incidence of nausea, vomiting, and PONV at 2–24 and 24–48 h after surgery in all four groups was not statistically significant. The incidence of total 24 h PONV in group LD (33.3%) was significantly decreased compared to group C (60.0%) ( P < 0.05). The cumulative consumption of fentanyl at 6 and 12 h after surgery was significantly reduced in group LD compared to other three groups ( P < 0.05). The pain VAS scores were significantly decreased at 2, 6, and 12 h after operation in group LD compared to other three groups ( P < 0.05). Remifentanil dose in the intraoperative period was significantly lower in groups LD and D compared with groups C and L ( P < 0.05). The number of mouth dry, bradycardia, and over sedation during the PACU stay period was markedly increased in group LD (28.3, 30.0, and 35.0%, respectively) compared with groups C (1.7, 1.7, and 3.3%, respectively) and L (3.3, 5.0, and 6.7%, respectively) ( P < 0.05). Conclusions Lidocaine combined with dexmedetomidine infusion markedly decreased the occurrence of nausea and PONV at 0–2 h as well as the total 24 h PONV. However, it significantly increased the incidence of mouth dry, bradycardia, and over sedation during the PACU stay period after laparoscopic hysterectomy with general anesthesia. Trial registration ClinicalTrials.gov ( NCT03809923 ), registered on January 18, 2019.

Effect of Dezocine on Postoperative Pain in Laparoscopic Patients

Dezocine For Preventing Postoperative Pain: A Meta-Analysis Of Randomized Controlled Trials

Postoperative Analgesic Effects Of Different Doses Of Epidural Hydromorphone Coadministered With Ropivacaine After Cesarean Section: A Randomized Controlled Trial

Evaluation on postoperative analgesia efficacy of oxycodone combined with dexmedetomidine in patients underwent laparoscopic radical surgery of colon cancer

Research of the Treatment Effects on Patient's Visceral Pain by Dezocine in Laparoscopic Cholecystectomy

Analgesic and Sedative Effects of Dezocine and Midazolam During Vitrectomy.

Reprint Of: Efficacy and Safety of Different Doses of Dezocine for Preemptive Analgesia in Gynecological Laparoscopic Surgeries: A Prospective, Double Blind and Randomized Controlled Clinical Trial.

Efficacy and safety of dezocine in postoperative pain relief: Systematic review and Meta-analysis

Clinical Observation of Dezocine Combined with Flurbiprofen for Postoperative Analgesia after Abdominal Surgeries: a Prospective Study

Clinical effect observation of epidural analgesia with dezocine and ropivacine after thoracic surgery

Efficacy of Dezocine in Enhancing Postoperative Patient-Controlled Epidural Analgesia with Bupivacaine

Analgesic effect of preoperative dezocine-based local anesthesia in patients undergoing inguinal hernia repair

Dezocine before induction enhances the postoperative analgesic effect in oral cancer patients

Preoperative Intravenous Administration Of Dezocine For Cesarean Section Under Epidural Anesthesia: Effects On Maternal Well-Being And Neonatal Outcome

Effect of Dezocine Combined with Propofol on Induced Abortion of Indolence

Clinical study on dezocine and sufentanil for postoperative analgesia in upper-abdominal surgery or hip replacement surgery

Effect of intravenous lidocaine combined with dexmedetomidine on postoperative nausea and vomiting after laparoscopic total hysterectomy

Effects of Lidocaine, Dexmedetomidine, and Their Combination Infusion on Postoperative Nausea and Vomiting Following Laparoscopic Hysterectomy: a Randomized Controlled Trial

Effects of dezocine for the prevention of postoperative catheter-related bladder discomfort: a prospective randomized trial.

Effect of Small Dose of Dexmedetomidine on Development of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Gynecologic Surgery

Effect of droperidol pretreatment on pain management and comfort in patients undergoing gynecologic laparoscopic surgery